(Q78214508)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10475620%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

title

Treatment of unfavorable myelodysplastic syndrome with all-trans-retinoic acid and subcutaneous Ara C (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10475620%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

main subject

myelodysplastic syndrome

1 reference

1 reference

5

M R Litzow

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10475620%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

author name string

L Letendre

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10475620%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

P Noel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10475620%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

W L White

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10475620%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

A Tefferi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10475620%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

C Y Li

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10475620%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

G Schroeder

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10475620%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

publication date

1 September 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10475620%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10475620%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10475620%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10475620%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

page(s)

811-815

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10475620%20AND%20SRC:MED&resulttype=core&format=json

Proposals for the classification of the myelodysplastic syndromes

12 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900095-8

7 January 2021

Myelodysplastic syndrome treatment with danazol and cis-retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900095-8

7 January 2021

1-B-D arabinofuranosyl cytosine and all-trans retinoic acid in combination accelerates and increases monocyte differentiation of myeloid leukemic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900095-8

7 January 2021

Retinoic acid alone and in combination with cytosine arabinoside induces differentiation of human myelomonocytic and monoblastic leukaemic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900095-8

7 January 2021

All-trans retinoic acid: tolerance and biologic effects in myelodysplastic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900095-8

7 January 2021

All-trans retinoic acid improves erythropoiesis in myelodysplastic syndromes: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900095-8

7 January 2021

All-trans retinoic acid in the treatment of myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900095-8

7 January 2021

All-trans retinoic acid plus low doses of cytarabine for the treatment of "poor-risk" acute myeloid leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900095-8

7 January 2021

Cytogenetic studies in 174 consecutive patients with preleukemic or myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900095-8

7 January 2021

A critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900095-8

7 January 2021

Low-dose ara-C in myelodysplastic syndromes (MDS) and acute leukemia following MDS: proposal for a predictive model

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900095-8

7 January 2021

10.1016/S0145-2126(99)00095-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10475620%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1 reference